| Literature DB >> 20300593 |
Govindan Dayanithi1, Isabelle Richard, Cédric Viero, Elsa Mazuc, Sylvie Mallie, Jean Valmier, Nathalie Bourg, Muriel Herasse, Isabelle Marty, Gérard Lefranc, Paul Mangeat, Stephen Baghdiguian.
Abstract
Mutations of Ca(2+)-activated proteases (calpains) cause muscular dystrophies. Nevertheless, the specific role of calpains in Ca(2+) signalling during the onset of dystrophies remains unclear. We investigated Ca(2+) handling in skeletal cells from calpain 3-deficient mice. [Ca(2+)](i) responses to caffeine, a ryanodine receptor (RyR) agonist, were decreased in -/- myotubes and absent in -/- myoblasts. The -/- myotubes displayed smaller amplitudes of the Ca(2+) transients induced by cyclopiazonic acid in comparison to wild type cells. Inhibition of L-type Ca(2+) channels (LCC) suppressed the caffeine-induced [Ca(2+)](i) responses in -/- myotubes. Hence, the absence of calpain 3 modifies the sarcoplasmic reticulum (SR) Ca(2+) release, by a decrease of the SR content, an impairment of RyR signalling, and an increase of LCC activity. We propose that calpain 3-dependent proteolysis plays a role in activating support proteins of intracellular Ca(2+) signalling at a stage of cellular differentiation which is crucial for skeletal muscle regeneration.Entities:
Year: 2010 PMID: 20300593 PMCID: PMC2838219 DOI: 10.1155/2009/340346
Source DB: PubMed Journal: Int J Cell Biol ISSN: 1687-8876
Figure 1Morphological and molecular features of skeletal muscle cells used throughout this study. (a) Phase contrast and fluorescence micrographs of murine skeletal muscle cells in primary culture. Typical morphology of the living cells (left upper panel: myoblasts; right upper panel: myotubes) used for calcium measurements observed by phase contrast microscopy. Circles indicate the region of drug application and monitoring of [Ca2+]. Immunological staining of myogenin on myoblasts (left middle panel) and myotubes (right middle panel) was visualized by confocal microscopy using a FITC-labelled secondary antibody (green fluorescence). Myosine Heavy Chain (MHC) was similarly observed in myoblasts (left lower panel) and myotubes (right lower panel) using a TRITC-labelled secondary antibody (red fluorescence). Myoblasts and myotubes were obtained after 6 or 11 days in culture, respectively. (b) Detection of calpain 3-mRNA in wild type (+/+) myoblasts and myotubes by RT-PCR. Gel electrophoresis of the RT-PCR reactions obtained using the primer pairs p94sys3, p94sys5 and p94sys6 (see Section 2) on murine myoblast (MB) or myotube (MT) mRNA. (c) Detection of the ryanodine receptor in skeletal muscle from normal and capn3-deficient mice. Muscle from normal (Lane 3) and capn3-deficient mice (Lane 2) were extracted and left 30 min at room temperature to allow the cleavage of RyR and were then subjected to SDS-PAGE. Human muscle was used as control (Lane1). No difference in the cleavage pattern was observed, indicating that the partial cleavage of RyR also occurs in the absence of calpain 3 in this biochemical assay. (d) Measurement of caspase 3 activity in wild type and capn3-deficient myoblasts. The graph displays the levels of substrate cleavage expressed as means ± S.D. in arbitrary units. The results are based on 4 different experiments. The differences in the median values among the two groups are greater than would be expected by chance; there is a statistically significant difference (P = 0.029), as indicated by a Mann-Whitney Rank Sum test.
Quantification of the expression of calpain 3 transcripts in wild type myoblasts and myotubes. These data were obtained from the gel electrophoresis of the RT-PCR reactions using the primer pairs p94sys3, p94sys5 and p94sys6 on murine myoblast (MB) or myotube (MT) mRNA (see Figure 1(b)). The gel and the corresponding quantification are representative of 3 different experiments where similar results were observed. These results have to be taken qualitatively since the experiments were performed by classical RT-PCR and not by quantitative RT-PCR. Numbers are given in arbitrary units.
| Primer | p94sys3 | p94sys5 | p94sys6 | |||
|---|---|---|---|---|---|---|
| Cell type | MB | MT | MB | MT | MB | MT |
| Band 1 | 43596 | 165378 | 155681 | 205283 | 66937 | 46845 |
| Band 2 | 207433 | 89706 | 73219 | 69370 | 45719 | |
| Band 3 | 43022 | |||||
| Total | 251029 | 255084 | 228900 | 274653 | 155678 | 46845 |
Western blot quantification: cleavage of the ryanodine receptor in wild type and calpain 3-deficient skeletal muscles. The gel presented in Figure 1(c) was analysed in terms of band intensities (numbers are given in arbitrary units). The lower band is 58% of the higher band (fixed to 100%) in lane 2, and 51% in lane 3. The amount of the second band is related to small degradation condition (time and temperature), but is always identical in the two situations wild type and calpain 3-deficient skeletal muscles. The blot and the corresponding quantification are representative of at least 3 independent experiments showing no difference between the two types of mice.
| Sample | 1 = human skeletal muscle | 2 = | 3 = wild type mouse skeletal muscle |
|---|---|---|---|
| Band 1 | 90982 | 69472 | 52878 |
| Band 2 | 92773 | 32041 | 38331 |
| Band 3 | 49076 | ||
| Total | 232831 | 101513 | 91209 |
Figure 2Effect of caffeine on [Ca2+] in isolated myoblasts and myotubes. Representative traces show the typical time course of the response to 20 mM caffeine observed in (a) wild type (+/+) myoblast; (b) wild type (+/+) myotube; (c) capn3-deficient (−/−) myoblast; (d) capn3-deficient (−/−) myotube. The duration of drug exposure is represented (open bars).
Figure 3Peak amplitude of [Ca2+] response of myoblasts and myotubes to caffeine. Bar diagrams summarize the response of the cell types shown in Figure 2. (a) myoblasts (+/+ and −/−): single application of 20 mM caffeine; (b) myotubes (+/+); (c) myotubes (−/−): 3 successive applications of 20 mM caffeine. The number of cells pooled in a category and the total number of cells tested are given in brackets.
Figure 4Effect of caffeine and CPA on [Ca2+] in isolated myoblasts and myotubes. Representative traces show the typical time course of the response to 20 mM caffeine and 10 μM CPA observed in (a) wild type (+/+) myoblast; (b) wild type (+/+) myotube; (c) calpain 3-deficient (−/−) myoblast; (d) calpain 3-deficient (−/−) myotube. The duration of exposure to caffeine (open bars) and CPA (gray-dashed bars) is represented.
Figure 5Peak amplitude of [Ca2+] response of myoblasts and myotubes to caffeine and CPA. Bar diagrams summarize the response of the cell types shown in Figure 4. (a) myoblasts (+/+); (b) myotubes (+/+); (c) myoblasts (−/−): application of 20 mM caffeine followed by 10 μM CPA; (d) myotubes (−/−): 2 successive applications of 20 mM caffeine followed by 10 μM CPA. The number of cells tested is given in brackets.
Figure 6Effect of caffeine on [Ca2+] in isolated myotubes in the presence of Ca2+ channel blockers (Ni2+/Cd2+). Representative traces show the typical time course of the response to 20 mM caffeine observed in (a) wild type (+/+) myotube; (c) calpain 3-deficient (−/−) myotube, each treated with Ni2+/Cd2+. The duration of exposure to caffeine (open bars), or 50 μM Ni2+/100 μM Cd2+ (closed bars) is represented. Bar diagrams (b) and (d) summarize the peak amplitude of the [Ca2+] response of myotubes to caffeine and CPA. The responses from the wild type myotubes (+/+; b) and calpain 3-deficient myotubes (−/−; d), are shown. Fifty μM Ni2+/100 μM Cd2+ was added to the extracellular medium prior to the second application. The number of cells tested is given in brackets.